VERONICA GARNER: Open Payments
NPI 1508467945 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$922 in 59 payments from 11 companies in 2025. Trend: 2023 $1,071 · 2024 $779 · 2025 $922
Food & beverage: $922
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 10 | $233 |
| ABBVIE INC. | 19 | $206 |
| Otsuka America Pharmaceutical, Inc. | 11 | $140 |
| Janssen Pharmaceuticals, Inc | 5 | $112 |
| Noven Therapeutics, LLC | 5 | $80 |
| Lundbeck LLC | 3 | $53 |
| Neos Therapeutics, LP | 2 | $35 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Almatica Pharma LLC | 1 | $15 |
Products named: VRAYLAR, Auvelity, REXULTI, SPRAVATO, Xelstrym, Sunosi, EXXUA, Adzenys XR-ODT.
Industry payments across OH — which companies pay providers there.
